CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease

OBJECTIVE: Alzheimer’s disease (AD) is the sixth leading cause of death, with an average survival estimated between 5 and 10 years after diagnosis. Despite recent advances in diagnostic criteria of AD, few studies have used biomarker-based diagnostics to determine the prognostic factors of AD. We in...

Descripción completa

Detalles Bibliográficos
Autores principales: Boumenir, Adla, Cognat, Emmanuel, Sabia, Severine, Hourregue, Claire, Lilamand, Matthieu, Dugravot, Aline, Bouaziz-Amar, Elodie, Laplanche, Jean-Louis, Hugon, Jacques, Singh-Manoux, Archana, Paquet, Claire, Dumurgier, Julien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440001/
https://www.ncbi.nlm.nih.gov/pubmed/30922415
http://dx.doi.org/10.1186/s13195-019-0481-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440001/
https://www.ncbi.nlm.nih.gov/pubmed/30922415
http://dx.doi.org/10.1186/s13195-019-0481-4

Ejemplares similares